Diagnosing COVID-19-associated pulmonary aspergillosis

Lancet Microbe, The - Tập 1 Số 2 - Trang e53-e55 - 2020
Paul E. Verweij1,2, Jean‐Pierre Gangneux3, Matteo Bassetti4,5, Roger J. M. Brüggemann1,6, Oliver A. Cornely7,8,9,10,11, Philipp Koehler8,9,10, Cornelia Lass‐Flörl12, Frank L. van de Veerdonk1,13, Arunaloke Chakrabarti14, Martin Hoenigl15,16
1Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands
2Departments of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands
3University of Rennes, Centre Hospitalier Universitaire (CHU) de Rennes, Inserm, EHESP, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France
4Clinica Malattie Infettive, Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere, Genoa, Italy
5Department of Health Sciences, University of Genoa, Genoa, Italy
6Department of Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands
7Clinical Trials Centre Cologne, Cologne, Germany
8Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Faculty of Medicine, University of Cologne, Cologne, Germany
9Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
10Excellence Center for Medical Mycology, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
11German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany
12Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria
13Dpeartment of Infectious Diseases, Radboud University Medical Centre, Nijmegen, Netherlands
14Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
15Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, CA, USA
16Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Gangneux, 2020, Invasive fungal diseases during COVID-19: we should be prepared, J Mycol Med, 10.1016/j.mycmed.2020.100971

Zhang, 2020, Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China, J Clin Virol, 127, 10.1016/j.jcv.2020.104364

Wang, 2003, Fatal aspergillosis in a patient with SARS who was treated with corticosteroids, N Engl J Med, 349, 507, 10.1056/NEJM200307313490519

Alanio A, Dellière S, Fodil S, Bretagne S, Bruno Mégarbane B. High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients. SSRN 2020; published online April 15. 3575581 (abstr).

Koehler, 2020, COVID-19 associated pulmonary aspergillosis, Mycoses, 10.1111/myc.13096

Schauwvlieghe, 2018, Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study, Lancet Respir Med, 6, 782, 10.1016/S2213-2600(18)30274-1

Meersseman, 2008, Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients, Am J Respir Crit Care Med, 177, 27, 10.1164/rccm.200704-606OC

Henriet, 2013, Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease, J Infect Dis, 207, 1932, 10.1093/infdis/jit103

Dewi IMW, Cunha C, Vanderbeke L, et al. Oseltamivir affects host defense against invasive pulmonary aspergillosis. European Conference on Clinical Microbiology and Infectious Diseases; Madrid; April 21–24, 2018. Abstract O1115.

Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, 10.1172/JCI137244

Wahidi, 2020, American Association for Bronchology and Interventional Pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection, J Bronchology Interv Pulmonol, 10.1097/LBR.0000000000000681